← Product Code [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX) · K022569 # PROLITE/PLASMALITE MPX PULSED LIGHT SYSTEM FOR TREATMENT OF VASCULAR LESIONS (K022569) _Medical Bio Care Sweden AB · GEX · Aug 29, 2002 · General, Plastic Surgery · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K022569 ## Device Facts - **Applicant:** Medical Bio Care Sweden AB - **Product Code:** [GEX](/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX.md) - **Decision Date:** Aug 29, 2002 - **Decision:** SESE - **Submission Type:** Special - **Regulation:** 21 CFR 878.4810 - **Device Class:** Class 2 - **Review Panel:** General, Plastic Surgery - **Attributes:** Therapeutic ## Intended Use The ProLite Pulsed Light System is intended to be used in the treatment of vascular lesions. ## Device Story The Prolite / Plasmalite MPX Pulsed Light System is a medical device designed for photothermolysis. It delivers pulsed light at a wavelength of 550 nanometers to treat vascular lesions. The system comprises three main components: a cabinet housing the power supply, cooling system, and microcontroller; an umbilical cord; and a handpiece containing the waveguide. The device is intended for use by healthcare professionals in clinical settings such as dermatology or plastic surgery offices. By delivering controlled light pulses, the device targets vascular structures to achieve therapeutic effects. The system is operated via a microcontroller-based interface. ## Clinical Evidence No clinical data provided; bench testing only. ## Technological Characteristics Pulsed light system operating at 550 nm wavelength. Components include a power supply, cooling system, microcontroller, umbilical, and handpiece with waveguide. Class II device under 21 CFR 878.4810. ## Regulatory Identification (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon. ## Predicate Devices - ProLite Pulsed Light System ([K010928](/device/K010928.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ DUPLICATE K022569/A' ## AUG 2 9 2002 ## Attachment I 510(K) Summary Prolite / Plasmalite MPX Pulsed Light System This 510(K) Summary of safety and effectiveness for the Prolite / Plasmalite MPX Pulsed Light System is submitted in accordance with the requirements of the SMDA 1990 and following guidance concerning the organization and content of a 510(K) summary. | Applicant: | Medical Bio Care AB | |---------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Address: | Lona Knapes gata 5
421 32 Vastra Frolunda,
Sweden | | Contact Person: | Morgan Gustafsson | | Telephone / Fax / Email | 46.31.709.30.70 - Phone
46.31.709.30.79 - Fax
morgan@medicalbiocare.com | | Preparation Date: | August 11, 2002 | | Device Trade Name: | Prolite / Plasmalite MPX Pulsed Light System | | Common Name: | Pulsed Light for Photothermolysis | | Classification Name: | Instrument, Surgical, Powered, laser
79-GEX, 21 CFR 878-48 | | Legally Marketed Predicate Device: | ProLite Pulsed Light System
K number 010928 | | Description of the Prolite / Plasmalite
MPX Pulsed Light System | The Prolite / Plasmalite MPX Pulsed Light System delivers
pulsed light at a wavelength of 550 nanometers. The device
consists of three interconnected sections: The cabinet which
houses the power supply, the cooling system and the
microcontroller, the umbilical to the handpiece, and the
handpiece, which houses the waveguide | | Intended use of the Prolite / Plasmalite
MPX Pulsed Light System | The Prolite / Plasmalite MPX Pulsed Light System is
indicated for the treatment of vascular lesions. | | Performance Data: | None | | Conclusion: | The ProLite / Plasmalite MPX Pulsed Light System is
substantially equivalent to other existing pulsed light
systems in commercial distribution for treatment of vascular
lesions in Dermatology and Plastic Surgery. | {1}------------------------------------------------ Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 ## AUG 2 9 2002 Medical Bio Care Sweden AB c/o Connie White Hoy 908 Stetson Street Woodland, California 95776 Re: K022569 Trade/Device Name: ProLite/Plasmalite MPX Pulsed Light System Regulation Number: 21 CFR 878.4810 Regulation Name: Laser Surgical Instrument for Use in General and Plastic Surgery and in Dermatology Regulatory Class: Class II Product Code: GEX Dated: July 25, 2002 Received: August 2, 2002 Dear Ms. Hoy : We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {2}------------------------------------------------ Page 2 - Ms. Connie White Hoy · This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely yours, Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {3}------------------------------------------------ ## INDICATION FOR USE STATEMENT 510(k) Number: _______________________________________________________________________________________________________________________________________________________________ K022569 Device Name: ProLite / Plasmalite MPX Pulsed Light System Indications for Use: The ProLite Pulsed Light System is intended to be used in the treatment of vascular lesions. (Please do not write below this line - Continue on another page if needed) Concurrence of CDRH, Office of Device Evaluation (ODE) Prescription Use_V (per 21 CFR 801.109) OR Over-the-Counter Use__________________________________________________________________________________________________________________________________________________________ Styt Plurde (Division Sign-Off) Division of General, Restorative and Neurological Devices 510(k) Number_KOZZS69 --- **Source:** [https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K022569](https://fda.innolitics.com/submissions/SU/subpart-e%E2%80%94surgical-devices/GEX/K022569) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com